{"id":18013,"date":"2020-04-07T15:00:48","date_gmt":"2020-04-07T19:00:48","guid":{"rendered":"https:\/\/www.benefitscanada.com\/news\/global-sales-of-mental-health-drugs-could-hit-us40b-by-2025-due-to-coronavirus-144874"},"modified":"2020-04-07T15:00:48","modified_gmt":"2020-04-07T19:00:48","slug":"global-sales-of-mental-health-drugs-could-hit-us40b-by-2025-due-to-coronavirus","status":"publish","type":"post","link":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/2020\/04\/07\/global-sales-of-mental-health-drugs-could-hit-us40b-by-2025-due-to-coronavirus\/","title":{"rendered":"Global sales of mental-health drugs could hit US$40B by 2025 due to coronavirus"},"content":{"rendered":"<div class=\"alignleft clearfix\">\n<div class=\"wp-caption feature-image alignleft\"> <img decoding=\"async\" loading=\"lazy\" width=\"316\" height=\"190\" src=\"https:\/\/www.benefitscanada.com\/wp-content\/uploads\/2016\/12\/PublicDrugs.png\" class=\"attachment-feature size-feature wp-post-image\" alt title=\"Global sales of mental-health drugs could hit US$40B by 2025 due to coronavirus\"> <\/div>\n<\/p><\/div>\n<p class=\"byline\"> <span>Staff<\/span>&nbsp;|&nbsp;April 7, 2020 <\/p>\n<p>The mental-health repercussions of the coronavirus could see global sales of psychiatric drugs increase to more than US$40 billion by 2025, according to data and analytics company GlobalData.<\/p>\n<p>Global sales for drugs to treat&nbsp;mental-health disorders such as depression, anxiety and obsessive compulsive disorder are expected to reach US$27.4 billion in 2020, an increase of US$717 million from 2019, the company said.&nbsp;It\u2019s forecasting a compound annual growth rate of 8.4 per cent from 2020 to 2025, to reach an estimated US$40.9 billion.<\/p>\n<p><strong>Read:&nbsp;<a href=\"https:\/\/www.benefitscanada.com\/news\/how-can-employers-support-employees-mental-health-during-coronavirus-144220\">How to support employees\u2019 mental health during coronavirus<\/a><\/strong><\/p>\n<p>\u201cPersonalized treatment strategies are important for treating psychiatric disorders, which may be exacerbated by the COVID-19 crisis,\u201d said Magdalene Crabbe, pharmaceutical analyst at GlobalData, in a press release.<\/p>\n<p>\u201cResponses to therapy are highly diverse and drugs that work for some people may not be effective for others. It is important that people realize that depending on pharmaceutical drugs is not necessarily the solution to the negative impact that COVID-19 will have on people\u2019s mental health. Recovering from the worst pandemic this century has experienced so far will be achieved through a combination of approaches, including psychotherapy, physiotherapy and financial assistance.\u201d<\/p>\n<p><strong>Read:&nbsp;<a href=\"https:\/\/www.benefitscanada.com\/news\/how-will-the-coronavirus-impact-long-term-disability-claims-144753\">How will the coronavirus impact long-term disability claims?<\/a><\/strong><\/p>\n<p> <a href=\"https:\/\/www.benefitscanada.com\/news\/global-sales-of-mental-health-drugs-could-hit-us40b-by-2025-due-to-coronavirus-144874\">Read the full article at BenefitsCanada.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Staff&nbsp;|&nbsp;April 7, 2020 The mental-health repercussions of the coronavirus could see global sales of psychiatric drugs increase to more than US$40 billion by 2025, according to data and analytics company GlobalData. Global sales for&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/18013"}],"collection":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/comments?post=18013"}],"version-history":[{"count":0,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/18013\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/media?parent=18013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/categories?post=18013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/tags?post=18013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}